Opioid Use Disorder Market, By Product Type (Buprenorphine (Oral, Parenteral, Others), Naloxone (Parenteral and Others (Nasal Spray, etc.)), Naltrexone (Oral and Parenteral), Combination Drugs, and Methadone), By Route of Administration (Parenteral (Extended release Injection for Subcutaneous, Intramuscular), Oral (Sublingual Tablet, Sublingual Film, Suspension), and Others), By Dosage Form (Injections, Sublingual film, Sublingual or Buccal, Tablet, Suspension, and Others), By Availability (Prescription and Over the Counter), By Brand (Sublocade, Suboxone, Brixadi, Vivitrol, Zubsolv, NARCAN, and Others), By Age Group (Adult and Children), By Type (Branded and Generic), By Indication (Opioid Addiction and Pain Management (Acute, Chronic)), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)